Author

Maoli Yuan

Observed name: M Yuan

Institutions: International AIDS Vaccine Initiative, Fred Hutch Cancer Center

Observed institutions: International AIDS Vaccine Initiative, SUNY Downstate Health Sciences University, Fred Hutch Cancer Center

ORCID: 0000-0002-1395-5418

Observed ORCID: 0000-0002-1395-5418

OpenAlex ID: A5078522041

Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty

2007 · Hui Shen, Qi Hua Gong, et al. · Nature Neuroscience · 243

Short-term steroid treatment increases δ GABAA receptor subunit expression in rat CA1 hippocampus: Pharmacological and behavioral effects

2005 · Hui Shen, Qi Hua Gong, et al. · Neuropharmacology · 161

Steroid withdrawal in the mouse results in anxiogenic effects of 3α,5β-THP: a possible model of premenstrual dysphoric disorder

2005 · Sheryl S. Smith, Yevgeniy Ruderman, et al. · Psychopharmacology · 133

Lactate induced excitotoxicity in hippocampal slice cultures

2004 · Zhongmin Xiang, Maoli Yuan, et al. · Experimental Neurology · 45

A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice

2014 · Svetlana Rabinovich, Rebecca L. R. Powell, et al. · PLoS ONE · 29

PDF

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera

2022 · Amy S. Espeseth, Maoli Yuan, et al. · EBioMedicine · 24

Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques

2017 · Mauricio A. Martins, Young C. Shin, et al. · PLoS Pathogens · 17

PDF

Mamu-B*17 + Rhesus Macaques Vaccinated with env , vif , and nef Manifest Early Control of SIVmac239 Replication

2018 · Mauricio A. Martins, Damien C. Tully, et al. · Journal of Virology · 16

PDF

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials

2022 · Christopher L. Cooper, Gavin Morrow, et al. · Vaccines · 14

PDF

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials

2025 · Christopher L. Cooper, Gavin Morrow, et al. · EBioMedicine · 11

The Stem of Vesicular Stomatitis Virus G Can Be Replaced With the HIV-1 Env Membrane-Proximal External Region Without Loss of G Function or Membrane-Proximal External Region Antigenic Properties

2014 · Ivo C. Lorenz, Hanh T. Nguyen, et al. · AIDS Research and Human Retroviruses · 6

GMP Manufacturing and Characterization of the HIV Booster Immunogen HxB2.WT.Core-C4b for Germline Targeting Vaccine Strategies

2025 · Sammaiah Pallerla, Latha Kallur Siddaramaiah, et al. · Vaccines · 2

PDF

Evaluation of a replication-competent VSV-SIV vaccine candidate

2012 · CK Jurgens, G Morrow, et al. · Retrovirology · 2

PDF

Viral vector delivery of Env trimer immunogens

2012 · CL Parks, S Rabinovich, et al. · Retrovirology

PDF

Development of candidate HIV vaccines using VSV vectors to express membrane-anchored MPER immunogen

2012 · M Yuan, A Wilson, et al. · Retrovirology

PDF

Optimizing expression of functional HIV envelopes in rVSV-ΔG vaccine vectors

2012 · KJ Wright, M Yuan, et al. · Retrovirology

PDF

Works count: 16

Citation count: 703

H-index: 10

I10-index: 10